Glenmark Pharmaceuticals Ltd

NSE: GLENMARK · BSE: 532296 · Pharmaceuticals & Biotechnology · 47 announcements

Share price

₹2,659.50

Market cap

₹75,058 Cr

Revenue (annual)

₹16,983 Cr

Net profit (annual)

₹1,362 Cr

P/E (TTM)

51.7×Sector 43.8×

Promoter holding

46.65%+0.00% QoQ

FII holding

21.51%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.